In the bustling, dynamic world of pharmaceuticals, every small change can ripple through the market significantly. Recently, the share price of Blau Farmacêutica (BLAU3) climbed 11.15% to R$10.66. This surge was tied to a pivotal decision by Brazil’s Supreme Court, a ruling that cleared the path for a significant auction of immunoglobulin. The court allowed […]
Related Posts
Rede D’Or São Luiz Sells D’Or Consultoria; Ambev Approves Share Repurchase
Rede D’Or São Luiz successfully sold its D’Or Consultoria stake to MDS Corretora e Administradora de Seguros on Thursday. Consequently, the valuation of D’Or Consultoria reached R$ 800 million ($155.34 million), with Rede D’Or holding 93.5% of the firm. Additionally, net debt and customary price adjustments will modify the purchase amount typical for such transactions. […]
Right-Wing Pride Grows in Brazil
Over the last decade, the University of São Paulo (USP) has observed Brazil’s political dynamics. They’ve seen a clear trend: right-wing protests are becoming more ideologically consistent. This trend was evident at a recent rally for ex-President Jair Bolsonaro, under investigation for potential coup involvement. The USP’s Public Policy Group for Access to Information (GPoPAI) […]
Brazilian Senate Committee Approves Landmark Gambling Bill
On June 19, Brazil’s Senate Constitution and Justice Committee (CCJ) greenlit a pivotal bill, led by Senator Irajá. Bill 2234/2022 aims to overhaul the nation’s gambling laws, passing with a close 14-12 vote. It now heads to the Senate floor for more rigorous scrutiny. This legislation would legalize casinos, lotteries, and horse betting across Brazil. […]